本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NovoCure Limited

17.06
-0.6500-3.67%
成交量:36.29万
成交额:627.24万
市值:19.02亿
市盈率:-11.28
高:17.86
开:17.59
低:16.97
收:17.71
数据加载中...
2025/07/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/06

重要事件披露

Form 8-K - Current report
2025/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/24

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/24

重要事件披露

Form 8-K - Current report
2025/04/22

重要事件披露

Form 8-K - Current report
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities